Viavi reported strong fiscal Q3 results, with revenue up 42.8% year over year to $406.8 million, EPS of $0.27 above guidance, and operating margin expanding 430 basis points year over year to 21%. NSE revenue surged 54.4% on data center and aerospace/defense demand, while management guided Q4 revenue to $427 million-$437 million and EPS to $0.29-$0.31. The call also highlighted accelerating demand in AI/data center testing, improving incremental margins, and continued debt paydown, with no buybacks in the quarter.
The real signal here is not just demand strength, but a mix shift that is converting a cyclical test-and-measurement vendor into a proxy for AI infrastructure capex plus defense modernization. That combination matters because it reduces dependence on service-provider spending, which historically capped multiples; as data-center exposure approaches half of NSE, the market should start valuing VIAV less like a slow utility-adjacent tester and more like an enabler of next-gen interconnect deployment. The second-order winner is likely suppliers of advanced silicon, optical packaging, and memory components that can keep up with VIAV’s early-access requirements, while smaller test vendors without comparable product breadth risk being displaced as packaging complexity rises. The earnings power inflects because this is now a high-fixed-cost model with unusually strong fall-through: incremental revenue is disproportionately monetized once the restructuring savings fully land over the next 2-3 quarters. The market may still be underestimating how much of the upside comes from operating leverage rather than pure top-line growth, especially since the company is also clearing debt and shrinking the cash drag from financing costs. That said, the near-term clean-up in cash flow is noisy: earn-outs, inventory builds, and convertible dilution can obscure the underlying cadence for at least one more quarter. The biggest risk is consensus extrapolation into a few quarters too many. If AI infrastructure spending pauses, or if co-packaged optics adoption slips from lab to production by even one cycle, the stock could de-rate quickly because the multiple is now being justified by a forward ramp, not just reported numbers. A more subtle bear case is that the defense and P&T uplift is real but smaller than the data-center story, so any hiccup in hyperscaler orders would leave investors overexposed to a single demand node. Bottom line: this looks like a 6-12 month compounding story, but not a straight line. The setup favors owning the stock on pullbacks rather than chasing after gap-ups, because the next catalyst is likely continued guidance credibility and restructuring realization rather than an immediate re-rating event.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
strongly positive
Sentiment Score
0.74
Ticker Sentiment